Common Variable Immunodeficiency-Associated Inflammatory Enteropathy: The New Era of Biological Therapy

Common variable immunodeficiency (CVID) is the most frequent form of immunodeficiency in adults. Clinical manifestations are heterogeneous with an increased susceptibility to infections and inflammatory conditions, namely autoimmune diseases, such as inflammatory bowel disease. We present the clinic...

ver descrição completa

Detalhes bibliográficos
Autor principal: Arieira,Cátia (author)
Outros Autores: Castro,Francisca Dias de (author), Moreira,Maria João (author), Cotter,José (author)
Formato: report
Idioma:eng
Publicado em: 2018
Assuntos:
Texto completo:http://scielo.pt/scielo.php?script=sci_arttext&pid=S2341-45452018000600008
País:Portugal
Oai:oai:scielo:S2341-45452018000600008
Descrição
Resumo:Common variable immunodeficiency (CVID) is the most frequent form of immunodeficiency in adults. Clinical manifestations are heterogeneous with an increased susceptibility to infections and inflammatory conditions, namely autoimmune diseases, such as inflammatory bowel disease. We present the clinical case of a Caucasian female patient, 21 years old, with a past medical history of CVID, with multiple visits to the emergency department due to abdominal pain in the lower quadrants and diarrhea. Her biochemical analysis showed elevated inflammatory parameters. Stool cultures and parasitological examination of feces were negative. Ileocolonoscopy revealed lymphoid nodular hyperplasia of the terminal ileum, and the small bowel capsule endoscopy demonstrated edema and multiple pleomorphic ulcers (Lewis score = 1,104). CVID-associated inflammatory enteropathy was suspected. Budesonide 9 mg/day was started, but no positive clinical response was observed. It was decided to initiate biological therapy with infliximab. The patient’s condition is currently clinically improved with no complications due to biological therapy.